Bixiye
Zoryve™ (roflumilast) - Commercial - Effective Date 02/01/2025
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Natiijooyinka Raadinta
Soo bandhiga 1481 - 1490 ee natiijooyinka 3686
Bixiye
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
P18-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P19-23 Updated Reimbursement Policy: Preventive Medicine Services, Effective June 5, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P21-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
Long Acting Insulin - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Afrezza® - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Hyftor™ (sirolimus) - Commercial - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025